Testing a new version of an obesity treatment pill
Part of Hormones & metabolism clinical trials.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 55 years old.
- You weigh at least 65 kg (about 143 lbs) and have a BMI between 24 and 35.
- Your weight has been stable (not changed by more than 5 kg) in the last 3 months.
- You are generally healthy, with no serious medical conditions like heart disease, uncontrolled high blood pressure, or stomach problems.
- You do not smoke heavily, drink a lot of alcohol, or use illegal drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational injection called HRS-4729 for weight loss in people with obesity. It checks if the drug is safe and effective when used along with diet and exercise.
This study tests a new medication called HS-20094 for people who are overweight or have obesity. It is designed to help with weight loss and will last for several months to see how safe and effective the medicine is.
This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.
This trial tests an oral medication, HRS9531, to help overweight or obese adults lose weight. It may be an option if you have been unable to lose enough weight through diet and exercise alone.
This trial is testing how different ways of taking an oral medication (HRS9531) affect the drug levels in the body. It is for healthy men to help find the best dosing conditions for future studies.
This study tests whether a new injectable medication called HRS9531 is safe and well-tolerated in teenagers aged 12–17 with obesity. Researchers will monitor how your body handles the medication and whether it affects your weight.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.